Showing results (251-260 of 471) with videos related to
Sort By:
Pageof 48
Cahiers De Sociologie Et De Demographie Medicales|July 1, 1996
[Standards, options and diagnostic and therapeutic recommendations in oncology. Fédération Nationale des Centres de Lutte contre le Cancer]B Fervers, L Labrèze, M Lehmann, et al.Bulletin Du Cancer|February 1, 1997
[Prevalence assessment of colorectal and breast cancers in the Rhône-Alpes area]M Colonna, F Ménégoz, C Exbrayat, et al.BMC Medical Education|February 13, 2024
Exploring experiential learning within interprofessional practice education initiatives for pre-licensure healthcare students: a scoping reviewDaniel A Nagel, Jamie L Penner, Gayle Halas, et al.Journal De Genetique Humaine|October 1, 1979
[Exclusion of MNSS, Kidd and Gm from the extreme end of the short portion of chromosome 8]B Biggio, T Philip, C Charrin, et al.Shock (Augusta, Ga.)|September 22, 2007
Transcriptional profiles of human epithelial cells in response to heat: computational evidence for novel heat shock proteinsJason M Laramie, T Philip Chung, Buddy Brownstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adultsJ Y Blay, D Bouhour, I Ray-Coquard, et al.International Journal of Clinical Practice|August 16, 2003
Management of colonic injury following percutaneous nephrolithotomyM Hussain, R Hamid, M Arya, et al.Bone Marrow Transplantation|March 21, 2000
Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 yearsS Kulkarni, R Powles, J Treleaven, et al.Bone Marrow Transplantation|March 29, 2000
Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-upS J Vaidya, A Atra, S Bahl, et al.Bone Marrow Transplantation|March 16, 2002
Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemiaS Singhal, R Powles, P J Henslee-Downey, et al.Pageof 48